Abstract
The investigation into SGR concentrates on pharmaceuticals and their active components, therapeutic interventions, and pharmacological mechanisms. Recently, anti-inflammatory and cyberpharmacology have emerged as prominent trends, indicating that the integration of animal studies with molecular bioinformatics to investigate the pharmacological mechanism of SGR is the main research direction in the future, while cardiovascular protection and neuroprotective effects have become significant areas of recent inquiry. Consequently, SGR is anticipated to be a functional plant for the treatment of various diseases.
Introduction
Smilax glabra Roxb (SGR), a plant central to both Traditional Chinese Medicine (TCM) and functional foods like "turtle jelly," has long been utilized for its therapeutic properties, particularly in treating hyperuricemia and gout. However, research on SGR has historically been fragmented across different languages and databases. This study presents the first systematic bibliometric analysis of SGR, synthesizing literature from 2000 to 2024 to map global research trends and identify future development prospects.
Methodology and Data Selection
To capture the full scope of SGR research, the authors employed a dual-language corpus. English literature (161 articles) was retrieved from the Web of Science Core Collection (WoSCC), while Chinese literature (1,562 articles) was gathered from CNKI, Wanfang, and VIP databases.
The researchers utilized CiteSpace 6.3.1, a specialized data visualization tool, to generate "knowledge maps." The workflow included co-occurrence analysis of authors and institutions, timeline analysis of keywords, and "burst detection" to identify emerging trends. Data was refined through de-duplication and manual screening to ensure a high-quality final set of 1,723 articles.
Evolution of Research Trends: From Plant to Pathway
The analysis reveals a significant "dual-track" growth pattern. While Chinese literature maintains a steady volume, English-language publications are on a distinct upward trajectory, suggesting SGR is gaining global pharmacological interest.
A thematic shift is evident over the last two decades. Early research (2000–2010) focused primarily on identifying active chemical compounds, such as the flavonoid astilbin. Modern research has pivoted toward "Network Pharmacology" (or cyberpharmacology). Rather than seeking a single active compound, researchers now use molecular bioinformatics to investigate how SGR’s complex chemical profile interacts with multiple biological pathways simultaneously. This shift is highlighted by the keyword "Network Pharmacology" having the highest emergence intensity (18.14) in recent years.
Key Findings and Publication Landscape
The study identified 15 major thematic clusters in Chinese literature and 17 in English, with "Gout," "Molecular Docking," and "Anti-inflammatory" appearing as core themes. Institutional dominance is centered in China, with the Beijing University of TCM leading in major publications.
As shown in the publication data, the Journal of Traditional Chinese Medicine and the Journal of Practical Traditional Chinese Medicine are the primary venues for SGR research, reflecting the plant's deep roots in clinical TCM practice.
Future Directions and Conclusion
While SGR shows immense promise, challenges remain regarding the bioavailability of its active components. Future research is expected to focus on novel dosage forms and delivery systems to enhance clinical viability. Furthermore, while gout remains the primary focus, the emergence of "cardiovascular protection" and "neuroprotective effects" as research hotspots suggests that SGR may soon find broader applications as a multi-target functional plant for various systemic diseases.
Summary updated